BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8266151)

  • 41. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.
    Javitt JC; Aiello LP; Chiang Y; Ferris FL; Canner JK; Greenfield S
    Diabetes Care; 1994 Aug; 17(8):909-17. PubMed ID: 7956643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Audit of referral of diabetic patients.
    Al-Khaldi YM; Khan MY; Khairallah SH
    Saudi Med J; 2002 Feb; 23(2):177-81. PubMed ID: 11938394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The English national risk-reduction programme for preservation of sight in diabetes.
    Gillibrand W; Broadbent D; Harding S; Vora J
    Mol Cell Biochem; 2004 Jun; 261(1-2):183-5. PubMed ID: 15362502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mobile diabetes eye care: experience in developing countries.
    Murthy KR; Murthy PR; Kapur A; Owens DR
    Diabetes Res Clin Pract; 2012 Sep; 97(3):343-9. PubMed ID: 22613266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.
    Rohan TE; Frost CD; Wald NJ
    BMJ; 1989 Nov; 299(6709):1198-201. PubMed ID: 2513049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus.
    Lueder GT; Silverstein J;
    Pediatrics; 2005 Jul; 116(1):270-3. PubMed ID: 15995070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model.
    Javitt JC; Canner JK; Frank RG; Steinwachs DM; Sommer A
    Ophthalmology; 1990 Apr; 97(4):483-94; discussion 494-5. PubMed ID: 2109299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for sight-threatening diabetic retinopathy.
    Cheng H; Franklin S
    Practitioner; 1987 Nov; 231(1439):1545-8. PubMed ID: 3505347
    [No Abstract]   [Full Text] [Related]  

  • 49. Programme planning and screening strategy in retinopathy of prematurity.
    Jalali S; Anand R; Kumar H; Dogra MR; Azad R; Gopal L
    Indian J Ophthalmol; 2003 Mar; 51(1):89-99. PubMed ID: 12701873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Costs of mobile screening for diabetic retinopathy: a practical framework for rural populations.
    Lee SJ; McCarty CA; Taylor HR; Keeffe JE
    Aust J Rural Health; 2001 Aug; 9(4):186-92. PubMed ID: 11488703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diabetic retinopathy: clinical features and new therapeutic findings].
    Rasquin F
    Rev Med Brux; 2003 Sep; 24(4):A310-6. PubMed ID: 14606295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Project diabetes 2000.
    McGroarty J
    N Y State J Med; 1992 Mar; 92(3):115-6. PubMed ID: 1557200
    [No Abstract]   [Full Text] [Related]  

  • 53. Implementation of a diabetic retinopathy referral network, Peru.
    Salamanca O; Geary A; Suárez N; Benavent S; Gonzalez M
    Bull World Health Organ; 2018 Oct; 96(10):674-681. PubMed ID: 30455515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Public health system integration of avoidable blindness screening and management, India.
    Gudlavalleti VS; Shukla R; Batchu T; Malladi BVS; Gilbert C
    Bull World Health Organ; 2018 Oct; 96(10):705-715. PubMed ID: 30455518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening and prevention of diabetic blindness.
    Stefánsson E; Bek T; Porta M; Larsen N; Kristinsson JK; Agardh E
    Acta Ophthalmol Scand; 2000 Aug; 78(4):374-85. PubMed ID: 10990036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme.
    Waqar S; Bullen G; Chant S; Salman R; Vaidya B; Ling R
    Diabetes Metab Syndr; 2012; 6(4):199-202. PubMed ID: 23199538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review.
    Swanson M
    Optometry; 2005 Nov; 76(11):636-46. PubMed ID: 16298316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic retinopathy in the developing world: how to approach identifying and treating underserved populations.
    Friedman DS; Ali F; Kourgialis N
    Am J Ophthalmol; 2011 Feb; 151(2):192-4.e1. PubMed ID: 21251492
    [No Abstract]   [Full Text] [Related]  

  • 59. [Active screening and early intervention of diabetic retinopathy in community service].
    Zou HD; He MG
    Zhonghua Yan Ke Za Zhi; 2016 Nov; 52(11):801-804. PubMed ID: 27852396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preservation of sight in diabetes: developing a national risk reduction programme.
    Garvican L; Clowes J; Gillow T
    Diabet Med; 2000 Sep; 17(9):627-34. PubMed ID: 11051281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.